顺灏股份(002565.SZ):子公司拟与云南喜科等共设云南通灏生物科技股份有限公司
格隆汇 9 月 14日丨顺灏股份(002565.SZ)公布,2020年9月14日,公司控股子公司云南绿新生物药业有限公司(“云南绿新”或“乙方”)、参股公司云南喜科科技有限公司(“云南喜科”或“丙方”)、上海绿馨电子科技有限公司(“上海绿馨”或“丁方”)、与云南通盈药业有限公司(“云南通盈”或“甲方”)签订了《合作协议书》,拟出资共同合作设立云南通灏生物科技股份有限公司。上述交易完成后,公司将间接持有合资公司45%股权。
此次合作共同设立合资公司是公司基于现有业务发展战略布局所做的规划,合作各方可以充分发挥各自的资源及管理优势,共同探索包括工业大麻成型雾化制品的研发、生产及工业大麻花叶及萃取后渣叶再造香料薄片在电子生物健康产品的市场机会,与公司现有研发成果和业务实现有效协同,优化公司在新型烟草制品、草本非烟产品及工业大麻产业链的布局。
此次签署的合作协议设立合资公司,出于谨慎投资原则考虑,公司将根据项目进展情况逐步进行资金投入,合资公司仅为公司参股公司,不会对公司财务状况及生产经营造成重大不利影响,且预计合资公司短期内不会产生较大盈利。合资公司设立完成后,有助于完善公司产业链,提高公司竞争力为公司寻求新的利润增长点。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.